BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 3802012)

  • 1. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases.
    Sun J; He S; Cen H; Zhou D; Li Z; Wang MY; Ke Q; Guo BP; Liao CC; Rong C; Zhong DN; Tan XH
    J Int Med Res; 2021 May; 49(5):3000605211013274. PubMed ID: 34034561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioimmunoblastic T-cell Lymphoma: An Unusual Case in an Octogenarian.
    Kanderi T; Goel S; Shrimanker I; Nookala VK; Singh P
    Cureus; 2020 Feb; 12(2):e6956. PubMed ID: 32190506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma.
    Shang Y; Fu X; Chang Y; Li Y; Zhang M
    Sci Rep; 2018 Aug; 8(1):12907. PubMed ID: 30150635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin lesions and neutrophilic leukemoid reaction in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of the literature.
    He J; Liang H
    Clin Case Rep; 2015 Jun; 3(6):483-8. PubMed ID: 26185653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma.
    Kameoka Y; Takahashi N; Itou S; Kume M; Noji H; Kato Y; Ichikawa Y; Sasaki O; Motegi M; Ishiguro A; Tagawa H; Ishizawa K; Ishida Y; Ichinohasama R; Harigae H; Sawada K
    Int J Hematol; 2015 Jun; 101(6):536-42. PubMed ID: 25739382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.
    Xu B; Liu P
    PLoS One; 2014; 9(3):e92585. PubMed ID: 24651162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
    Federico M; Rudiger T; Bellei M; Nathwani BN; Luminari S; Coiffier B; Harris NL; Jaffe ES; Pileri SA; Savage KJ; Weisenburger DD; Armitage JO; Mounier N; Vose JM
    J Clin Oncol; 2013 Jan; 31(2):240-6. PubMed ID: 22869878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
    Mourad N; Mounier N; Brière J; Raffoux E; Delmer A; Feller A; Meijer CJ; Emile JF; Bouabdallah R; Bosly A; Diebold J; Haioun C; Coiffier B; Gisselbrecht C; Gaulard P;
    Blood; 2008 May; 111(9):4463-70. PubMed ID: 18292286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful coil embolization of a ruptured hepatic aneurysm in a patient with polyarteritis nodosa accompanied by angioimmunoblastic T cell lymphoma.
    Nakashima M; Suzuki K; Okada M; Takada K; Kobayashi H; Hama Y
    Clin Rheumatol; 2007 Aug; 26(8):1362-4. PubMed ID: 17106619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoblastic sarcoma arising in angioimmunoblastic lymphadenopathy.
    Olgun N; Tavli V; Kavukcu S; Cevik N; Gogus S; Cevik N
    Indian J Pediatr; 1993; 60(5):688-92. PubMed ID: 8157341
    [No Abstract]   [Full Text] [Related]  

  • 11. Angioimmunoblastic lymphadenopathy: clinical and radiological features.
    Limpert J; MacMahon H; Variakojis D
    Radiology; 1984 Jul; 152(1):27-30. PubMed ID: 6729133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioimmunoblastic lymphadenopathy: an etiology for gastrointestinal lymphomatous polyposis.
    Goenka MK; Vaiphei K; Nagi B; Sriram PV; Joshi K; Kochhar R
    Am J Gastroenterol; 1996 Jun; 91(6):1236-8. PubMed ID: 8651178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.
    Sallah S; Gagnon GA
    Acta Haematol; 1998; 99(2):57-64. PubMed ID: 9554450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in angioimmunoblastic lymphadenopathy.
    Archimbaud E; Coiffier B; Bryon PA; Vasselon C; Brizard CP; Viala JJ
    Cancer; 1987 Jan; 59(2):208-12. PubMed ID: 3802012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.
    Siegert W; Nerl C; Agthe A; Engelhard M; Brittinger G; Tiemann M; Lennert K; Huhn D
    Ann Oncol; 1995 Sep; 6(7):659-64. PubMed ID: 8664186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioimmunoblastic lymphadenopathy with dysproteinemia. Circulating immune complexes and the review of 18 cases.
    Coupland RW; Pontifex AH; Salinas FA
    Cancer; 1985 May; 55(9):1902-6. PubMed ID: 3978574
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.